Search Results
Oct 23, 2025, 08:10 ET AdCreative.ai, an Appier Group Company, Launches Mobile App to Put Professional Ad Creation in Everyone's Pocket
anywhere, directly from their phones." About Appier Appier (TSE: 4180) is a leading AI SaaS company that helps enterprises across industries leverage AI to drive sustainable growth. Appier enables brands to harness
More news about: AdCreative.ai, an Appier Group Company
Oct 23, 2025, 08:10 ET AdCreative.ai, an Appier Group Company, Launches Mobile App to Put Professional Ad Creation in Everyone's Pocket
from their phones." About Appier Appier (TSE: 4180) is a leading AI SaaS company that helps enterprises across industries leverage AI to drive sustainable growth. Appier enables brands to harness
More news about: AdCreative.ai, an Appier Group Company
Oct 23, 2025, 08:10 ET AdCreative.ai, ein Unternehmen der Appier Group, bringt eine mobile App auf den Markt, die professionelle Anzeigenerstellung für jedermann zugänglich macht
leistungsstarke Anzeigen erstellen." Informationen zu Appier Appier (TSE: 4180) ist ein führendes KI-SaaS-Unternehmen, das Unternehmen aller Branchen dabei unterstützt, KI zu nutzen, um nachhaltiges Wachstum zu erzielen. Appier
More news about: AdCreative.ai, an Appier Group Company
Oct 23, 2025, 08:10 ET AdCreative.ai, une société du groupe Appier, lance une application mobile pour mettre la création publicitaire professionnelle à la portée de tous.
à partir de leur téléphone. » À propos d'Appier Appier (TSE : 4180) est une société SaaS leader dans le domaine de l'IA qui aide les entreprises de tous les secteurs à tirer parti de l'IA pour stimuler une croissance
More news about: AdCreative.ai, an Appier Group Company
Oct 23, 2025, 08:00 ET Astellas and the Internet's Favorite Grandma, Barbara 'Babs' Costello, Partner to Encourage Others to Get Ahead of Geographic Atrophy (GA)
NORTHBROOK, Ill., Oct. 23, 2025 /PRNewswire/ -- Astellas Pharma US Inc. (TSE: 4503, Head of US Commercial: Michael Petroutsas, "Astellas"), maker of IZERVAY™ (avacincaptad pegol intravitreal solution), today announced a partnership
More news about: Astellas Pharma Inc.
Oct 22, 2025, 10:39 ET The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies
manufacturing sites and six innovation and development centers across the globe. Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology.
More news about: Terumo Blood and Cell Technologies
Oct 22, 2025, 08:00 ET Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study
TOKYO, Oct. 22, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced new real-world preliminary data from the OPTION-VMS Phase IV, longitudinal, observational
More news about: Astellas Pharma Inc.
Oct 21, 2025, 20:25 ET Innovent Biologics Announces Global Strategic Partnership with Takeda to Bring Innovent's Next Gen IO Backbone Therapy and ADC Molecules to the Global Market
Oct. 21, 2025 /PRNewswire/ -- Innovent Biologics (HKEX: 01801) announced a strategic global collaboration with Takeda (TSE:4502, NYSE:TAK) to advance next-generation IO and ADC cancer therapies, with the goal of developing potentially transformative cancer treatments to benefit
More news about: Innovent Biologics
Oct 21, 2025, 19:30 ET PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer
TOKYO, Oct. 22, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a
More news about: Astellas Pharma Inc.
Oct 21, 2025, 08:00 ET The NAMM Show Takes Home the Gold at Trade Show Executive's 2025 Gold 100 Awards
Association of Music Merchants), the largest global non-profit music trade organization, received the highest honors from the annual Trade Show Executive (TSE) Gold 100 Awards & Summit. The association won two highly competitive Grand Awards, the Fastest-Growing Gold 100 Retail Show in 2024 and
More news about: NAMM (National Association of Music Merchants)
Oct 19, 2025, 19:30 ET IZERVAY™ (avacincaptad pegol intravitreal solution) Showed Increased Benefit in Reducing Geographic Atrophy Progression Over Time and Consistent Long-Term Safety
TOKYO, Oct. 19, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the first results from the open-label extension trial of the Phase 3 GATHER2 study,
More news about: Astellas Pharma Inc.
Oct 18, 2025, 10:30 ET PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
TOKYO and NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced positive results from the pivotal Phase 3 EV-303 clinical
More news about: Astellas Pharma Inc.
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trinseo PLC - TSE
Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Trinseo PLC ("Trinseo" or the "Company") (NYSE: TSE). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Oct 17, 2025, 18:42 ET WhippleWood CPAs PC Joins Money Forward™ Partners to Accelerate Tech-Enabled Client Service
relationships and smart automation—helping firms work smarter, respond faster, and deliver greater value. Backed by Japan-based Money Forward, Inc. (TSE: 3994), the team's mission is to combine human connection with cutting-edge productivity to redefine how accounting firms operate.
More news about: Money Forward Partners
Oct 17, 2025, 11:45 ET Trend Micro and WDH Launch Magna AI, A Full-Value -Chain Global Enterprise AI Transformation Factory
TSE: 4704), a global cybersecurity leader, announced the entrance into a letter of intent to form Magna AI, in partnership with Wistron Digital Technology
More news about: Trend Micro Incorporated
Oct 17, 2025, 10:04 ET Equip Exposition Wins Greatest Trade Show Award in Trade Show Executive's Gold 100 Awards and Summit
held in the U.S. and offers associations and independent show organizers an opportunity to highlight their achievements. The awards were presented at a TSE Summit in Palm Springs, CA. Photo Caption (left to right):Chuck Bowen, Vice President, Communications
More news about: Equip Exposition
Oct 16, 2025, 08:00 ET UATP Partners with Burbank to Deliver Card-Present over Internet® Solutions to Airline Merchants
payment for corporate business travel worldwide by airlines, travel agencies, and Amtrak®; UATP accounts are issued by: Aeromexico; AERTiCKET; Air Canada (TSE: AC); Air China; Air New Zealand (ANZFF.PK); Air Niugini; AirPlus International a wholly owned subsidiary of SEB Kort; Akbar Travels; American Airlines
More news about: UATP
Oct 15, 2025, 14:11 ET Trend Micro Named a Leader in Network Analysis and Visibility
TSE: 4704) announced today that it has been named a Leader in Network Analysis and Visibility (NAV) solutions by Forrester. The analyst firm's independent
More news about: Trend Micro Incorporated
Oct 15, 2025, 08:30 ET EquiLend's 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow
of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, and National Bank of Canada (TSE: NA) began executing trades utilizing 1Source's distributed ledger technology (DLT) to increase efficiency, reduce breaks, and eliminate reconciliations.
More news about: EquiLend
Oct 15, 2025, 08:30 ET EquiLend's 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow
industry, today announced that The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, and National Bank of Canada (TSE: NA) began executing trades utilizing 1Source's distributed ledger technology (DLT) to increase efficiency, reduce breaks, and eliminate reconciliations.
More news about: EquiLend
Oct 14, 2025, 20:00 ET Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society
TOKYO, Oct. 14, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that VEOZAH™ (fezolinetant), its first-in-class, targeted, non-hormonal treatment
More news about: Astellas Pharma Inc.
Oct 13, 2025, 14:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trinseo PLC - TSE
Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Trinseo PLC ("Trinseo" or the "Company") (NYSE: TSE). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Oct 10, 2025, 08:49 ET Fixstars Adds Autonomous Optimization Feature for Edge AI Inference to its AI Acceleration Platform "AIBooster"
IRVINE, Calif., Oct. 10, 2025 /PRNewswire/ -- Fixstars Corporation (TSE Prime: 3687, US Headquarters: Irvine, CA), a leading company in performance engineering technology, today announced the release of the latest version
More news about: Fixstars
Oct 09, 2025, 08:55 ET Hitachi Vantara Collaborates with Supermicro to Deliver Superior Performance and Scale for Mission-Critical Applications and Enterprise AI
Hitachi Vantara, the data storage, infrastructure and hybrid cloud management subsidiary of Hitachi Ltd. (TSE: 6501), today announced it is working towards a strategic partnership with
More news about: Hitachi Vantara
Oct 08, 2025, 19:30 ET Astellas to Present New Data on IZERVAY™ (avacincaptad pegol intravitreal solution) in Geographic Atrophy at AAO 2025 Annual Meeting
TOKYO, Oct. 8, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced new data for IZERVAY™ (avacincaptad pegol intravitreal solution) for the treatment
More news about: Astellas Pharma Inc.